• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Current pathophysiological aspects of systemic sclerosis].

作者信息

Krieg T, Hunzelmann N

机构信息

Klinik und Poliklinik für Dermatologie und Venerologie, Universität zu Köln, Joseph-Stelzmann-Strasse 9, 50924, Köln, Germany.

出版信息

Z Rheumatol. 2006 Jul;65(4):275-8. doi: 10.1007/s00393-006-0066-z.

DOI:10.1007/s00393-006-0066-z
PMID:16807741
Abstract

Systemic scleroderma is characterized by a chronic inflammatory process of unknown etiology resulting in an increased deposition of connective tissue proteins in the involved organs. Involvement of the vascular system and the resulting fibrosis lead to atrophy and malfunction of the involved internal organs and the skin. Due to the development of new therapeutic concepts in particular with regard to the vascular involvement, the interaction between the vascular system and the connective tissue moves increasingly into focus. This review describes the major advancemades during recent years for the understanding of the pathophysiology of systemic scleroderma.

摘要

相似文献

1
[Current pathophysiological aspects of systemic sclerosis].
Z Rheumatol. 2006 Jul;65(4):275-8. doi: 10.1007/s00393-006-0066-z.
2
[Pathogenesis of systemic sclerosis].[系统性硬化症的发病机制]
Hautarzt. 2007 Oct;58(10):838, 840-3. doi: 10.1007/s00105-007-1392-z.
3
[Pathophysiology of fibroses. Progressive systemic scleroderma as a model disease].[纤维化的病理生理学。以进行性系统性硬化症为例的模型疾病]
Hautarzt. 1988 Feb;39(2):65-71.
4
The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?博来霉素诱导的硬皮病模型:我们对硬皮病发病机制有哪些了解?
Arch Dermatol Res. 2006 Feb;297(8):333-44. doi: 10.1007/s00403-005-0635-z. Epub 2006 Jan 10.
5
Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1.成纤维细胞基质基因表达与结缔组织重塑:内皮素-1的作用
J Invest Dermatol. 2001 Mar;116(3):417-25. doi: 10.1046/j.1523-1747.2001.01256.x.
6
Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis.成纤维细胞与基质的相互作用及其在纤维化发病机制中的作用。
Rheum Dis Clin North Am. 1990 Feb;16(1):93-107.
7
Pathophysiology of scleroderma: an update.硬皮病的病理生理学:最新进展
J Eur Acad Dermatol Venereol. 1998 Jul;11(1):1-8.
8
[Systemic sclerosis].[系统性硬化症]
Nihon Rinsho. 2009 Mar;67(3):519-22.
9
Control of fibrosis in systemic scleroderma.系统性硬化症中纤维化的控制
J Invest Dermatol. 1993 Jan;100(1):92S-96S. doi: 10.1111/1523-1747.ep12356293.
10
Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.缺氧诱导系统性硬化症中细胞外基质蛋白产生增加。
Arthritis Rheum. 2007 Dec;56(12):4203-15. doi: 10.1002/art.23074.

本文引用的文献

1
The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis.血管内皮生长因子(VEGF)、血管内皮生长因子受体-2(VEGFR-2)和葡萄糖转运蛋白1(GLUT-1)蛋白在系统性硬化症疾病亚型中的差异表达。
Hum Pathol. 2006 Feb;37(2):190-7. doi: 10.1016/j.humpath.2005.10.007. Epub 2005 Dec 15.
2
Signalling and regulation of collagen I synthesis by ET-1 and TGF-beta1.内皮素-1和转化生长因子-β1对I型胶原蛋白合成的信号传导与调控
FEBS J. 2005 Dec;272(24):6297-309. doi: 10.1111/j.1742-4658.2005.05016.x.
3
Attenuated liver fibrosis in the absence of B cells.
在缺乏B细胞的情况下肝纤维化减轻
J Clin Invest. 2005 Nov;115(11):3072-82. doi: 10.1172/JCI24798.
4
Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: important pathogenetic steps in early and late stage of systemic scleroderma?白细胞介素4和长期缺氧可诱导赖氨酰羟化酶2的基因表达升高并改变交联模式:这是系统性硬化症早期和晚期重要的发病机制步骤吗?
Matrix Biol. 2005 Oct;24(7):459-68. doi: 10.1016/j.matbio.2005.07.002. Epub 2005 Sep 1.
5
Overexpression of cathepsin K during silica-induced lung fibrosis and control by TGF-beta.组织蛋白酶K在二氧化硅诱导的肺纤维化过程中的过表达及转化生长因子-β的调控作用
Respir Res. 2005 Jul 27;6(1):84. doi: 10.1186/1465-9921-6-84.
6
Elevated matrix metalloproteinase-9 in patients with systemic sclerosis.系统性硬化症患者中基质金属蛋白酶-9升高。
Arthritis Res Ther. 2005;7(1):R71-9. doi: 10.1186/ar1454. Epub 2004 Nov 10.
7
Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.在小鼠纤维化模型中,结缔组织生长因子导致由转化生长因子-β诱导的持续性原α2(I)型胶原基因表达。
J Cell Physiol. 2005 May;203(2):447-56. doi: 10.1002/jcp.20251.
8
Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement.系统性硬化症患者的可溶性黏附分子(sVCAM-1、sE-选择素)、血管内皮生长因子(VEGF)和内皮素-1:与器官系统受累的关系
Clin Rheumatol. 2005 Apr;24(2):111-6. doi: 10.1007/s10067-004-0987-3. Epub 2004 Sep 3.
9
Defective vasculogenesis in systemic sclerosis.系统性硬化症中血管生成缺陷。
Lancet. 2004;364(9434):603-10. doi: 10.1016/S0140-6736(04)16853-0.
10
Transgenic analysis of scleroderma: understanding key pathogenic events in vivo.硬皮病的转基因分析:了解体内关键致病事件。
Autoimmun Rev. 2004 Jun;3(4):285-93. doi: 10.1016/j.autrev.2003.10.003.